Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 11-12, 2010, Pages 831-838

  Östholm Balkhed, Åse ^a,b   Tärnberg, Maria ^b   Nilsson, Maud ^b   Johansson, Anita V ^a   Hanberger, Häkan ^a,b   Monstein, Hans Jürg ^a,b   Nilsson, Lennart E ^a,b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIVMECILLINAM; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL LABORATORY; DRUG USE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PHENOTYPE; PREVALENCE; SWEDEN; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; SWEDEN; YOUNG ADULT;

EID: 78549280595     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.498017     Document Type: Article

References (39)

1. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
2. Paterson DL, Bonomo RA. Extended-spectrum betalactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-86.
3. The European Antimicrobial Resistance Surveillance System (EARSS). Annual report 2007. EARSS, Bilthoven, The Netherlands 2007;58-71.
4. Bonnet R. Growing group of extended-spectrum betalactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
5. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59: 165-74.
6. ß-Lactamase Classifi cation and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant Enzymes. .
7. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extendedspectrumbeta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(Suppl 1):144-53.
8. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13:1-11.
9. Alsterlund R, Carlsson B, Gezelius L, Haeggman S, Olsson-Liljequist B. Multiresistant CTX-M-15 ESBLproducing Escherichia coli in southern Sweden: description of an outbreak. Scand J Infect Dis 2009;41:410-5.
10. Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extendedspectrum beta-lactamase involved in an outbreak in longterm- care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004;48:3758-64.
11. Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A. The fi rst major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M- 15. APMIS 2008;116:302-8.
12. Mamlouk K, Boutiba-Ben Boubaker I, Gautier V, Vimont S, Picard B, Ben Redjeb S, Arlet G. Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 2006;44:4049-56.
13. Naseer U, Natas OB, Haldorsen BC, Bue B, Grundt H, Walsh TR, Sundsfjord A. Nosocomial outbreak of CTX-M- 15-producing E. coli in Norway. APMIS 2007;115:120-6.
14. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004; 54:735-43.
15. F orssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, et al. Emergence of ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates during the years 2000 and 2004 in Helsinki, Finland. Clin Microbiol Infect 2009; [Published online 14 Oct 2009].
16. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278-82.
17. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, et al. Increasing resistance to fl uoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000;46:223-8.
18. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect 2009;15(Suppl 3):12-5.
19. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579-87.
20. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008;14:1722-30.
21. Urbanek K, Kolar M, Loveckova Y, Strojil J, Santava L. Infl uence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumonia strains. J Clin Pharm Ther 2007;32:403-8.
22. The Swedish Reference Group for Antibiotics (SRGA) and Subcommittee on Methodology (SRGA-M). Disk diffusion. SRGA; 2009. Available at: http://www.srga.org/RAFMETOD/rafmet.htm (Accessed 3rd September 2009).
23. Monstein HJ, Tarnberg M, Nilsson LE. Molecular identify cation of CTX-M and blaOXY/K1 beta-lactamase genes in Enterobacteriaceae by sequencing of universal M13-sequence tagged PCR-amplicons. BMC Infect Dis 2009;9:7.
24. World Health Organization. The anatomical therapeutic chemical classifi cation system with defi ned daily doses. Oslo, Norway: WHO; 2005.
25. Capella D. Descriptive tools and analysis. WHO Reg Publ Eur Ser 1993;45:55-78.
26. The European Antimicrobial Resistance Surveillance System (EARSS). EARSS interactive database access. Available at: http://www.rivm.nl/earss/database (Accessed 6th October 2009).
27. Kjerulf A, Hansen DS, Sandvang D, Hansen F, Frimodt- Moller N. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS 2008;116:118-24.
28. Danish Integrated Antimicrobial resistance Monitoring and Research Programme (DANMAP). Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Copenhagen: DANMAP; 2007.
29. NORM/NORM-VET Tromso/Oslo. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway; 2007.
30. SWEDRES. The Swedish Strategic Programme against Antibiotic Resistance and the Swedish Institute for Infectious Disease Control, Solna, Sweden. A report on Swedish antimicrobial utilisation and resistance in human medicine; 2007.
31. Borg MA, van de Sande-Bruinsma N, Scicluna E, de Kraker M, Tiemersma E, Monen J, Grundmann H. Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect 2008;14:789-96.
32. Hallgren H, Gustafsson I, Ripa T. [ESBL -i ncreasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections]. Lakartidningen 2007;104:3883-5.
33. Rossolini GM, D A ndrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 2008;14(Suppl 1):33-41.
34. Pitout JD, Laupland KB. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159-66.
35. Nyberg SD, Osterblad M, Hakanen AJ, Huovinen P, Jalava J. The Finnish Study Group for Antimicrobial Resistance. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002 - 2004. Scand J Infect Dis 2007;39:417-24.
36. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 2008;46:707-12.
37. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A. Effects of phenotype and genotype on methods for detection of extendedspectrum- beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007;45:199-205.
38. Andre M, Vernby A, Odenholt I, Lundborg CS, Axelsson I, Eriksson M, et al. Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: consultations, diagnosis, diagnostics and treatment choices. Scand J Infect Dis 2008;40:648-54.
39. Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers diarrhoea. Scand J Infect Dis 2010;42:275-80.